RE
MRNA icon

RBC Europe’s Moderna MRNA Stock Holding History

RBC Europe’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$220K Hold
1,538
– – 0.01% 196
2022
Q1 		$265K Buy
1,538
+5
+0.3% +$842 0.01% 198
2021
Q4 		$389K Sell
1,533
-890
-37% -$260K 0.02% 168
2021
Q3 		$933K Sell
2,423
-229
-9% -$84.5K 0.04% 147
2021
Q2 		$623K Buy
2,652
+130
+5% +$23.2K 0.03% 183
2021
Q1 		$330K Buy
2,522
+917
+57% +$133K 0.02% 224
2020
Q4 		$168K Sell
1,605
-235
-13% -$23.8K 0.01% 312
2020
Q3 		$130K Buy
1,840
+460
+33% +$32.1K 0.01% 315
2020
Q2 		$88.6K Sell
1,380
-2,915
-68% -$160K 0.01% 350
2020
Q1 		$129K Buy
+4,295
New +$98.8K 0.01% 263

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RBC Europe's MRNA Position: Q2 2022 in Review

RBC Europe held its Moderna (MRNA) position steady in Q2 2022 at 1,538 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #196.

RBC Europe first reported a position in MRNA in Q1 2020 and has held it in 10 quarters since. The position peaked at $933K in Q3 2021. 982 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • RBC Europe held 1,538 shares of Moderna worth $220K as of Q2 2022.
  • RBC Europe left its Moderna share count unchanged in Q2 2022.
  • Moderna made up 0.01% of RBC Europe's portfolio in Q2 2022, its #196 holding.
  • RBC Europe first reported a position in Moderna in Q1 2020 and has held it in 10 quarters since.
  • RBC Europe's Moderna position peaked at $933K in Q3 2021.
  • 982 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.